SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Insecticides shines on receiving patent for insecticidal combination

30 Jul 2019 Evaluate

Insecticides (India) is currently trading at Rs. 678.25, up by 13.40 points or 2.02% from its previous closing of Rs. 664.85 on the BSE.

The scrip opened at Rs. 689.95 and has touched a high and low of Rs. 691.10 and Rs. 678.25 respectively. So far 114 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 800.00 on 07-Aug-2018 and a 52 week low of Rs. 370.00 on 11-Oct-2018.

Last one week high and low of the scrip stood at Rs. 691.10 and Rs. 650.00 respectively. The current market cap of the company is Rs. 1374.10 crore.

The promoters holding in the company stood at 68.75%, while Institutions and Non-Institutions held 18.96% and 12.29% respectively.

Insecticides India has received patent for an insecticidal combination and process thereof which covers ‘Suspension Concentrate (SC) Formulation Comprising Buprofezin and Fipronil’ for the term of 20 years from December 02, 2014 (Date of Filling). The company has received patent from the Government of India.  The combination is sold by the company under the brand name ‘Aikido’.

Insecticides India is a leading agro-chemical and pesticides manufacturer. It has formulation facilities in Chopanki (Rajasthan), Samba and Udhampur (Jammu & Kashmir) and Dahej (Gujarat).

Insecticides India Share Price

722.05 10.10 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×